Table 1. Baseline Characteristics of the Study Patients.
| Parameter | Value |
|---|---|
| Age (year) | Median, 66.5 (IQR, 60.0–72.5) |
| PSA (ng/dL) | Median, 5.0 (IQR, 3.8–8.3) |
| Interval between MRI and biopsy (day) | Median, 44.5 (IQR, 24.0–69.5) |
| Core number of targeted biopsy (n) | Median, 3.0 (IQR, 2.0–4.0) |
| Zonal location (%) | |
| PZ | 73.9 (68/92) |
| TZ | 26.1 (24/92) |
| Cancer detection rate of targeted biopsy (%) | |
| Any Pca | 46.7 (43/92) |
| csPCa | 40.2 (37/92) |
| ISUP grade (%) | |
| 1 | 14.0 (6/43) |
| 2 | 44.2 (19/43) |
| 3 | 16.3 (7/43) |
| 4 | 14.0 (6/43) |
| 5 | 11.6 (5/43) |
csPCa = clinically significant PCa, IQR = interquartile range, ISUP = International Society of Urological Pathology, MRI = magnetic resonance imaging, PCa = prostate cancer, PSA = prostate-specific antigen, PZ = peripheral zone, TZ= transition zone